drugset / Trial / NCT06667037
Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control
Recruiting
194 enrolled
Zhongshan Ophthalmic Center, Sun Yat-sen University
Henan Provincial People's Hospital · collabPeople's Hospital of Guangxi · collabTianjin Medical University Eye Hospital · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this multicenter randomized clinical trial is to evaluate the myopia control effect of orthokeratology and 0.01% atropine sequential treatment in children and adolescents, as compared to continuous treatment with orthokeratology.
Timeline
- Start
- 2024-09-21
- Primary completion
- 2026-12-31
- Completion
- 2027-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atropine | Other / unclassified | 0.01 % | Other |